OceƱa, Jessa Mae .
HRN: 14-91-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
CEFUROXIME 1.5GM (VIAL)
04/24/2023
04/25/2023
IV
1.5GM
Q8 X 6 DOSES
Infected Vulva
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes